Us2.v2
Overview
Us2.v2 by Eko.ai Pte. Ltd. (d/b/a Us2.ai) is an advanced, vendor-neutral image post-processing software designed to automate the analysis and reporting of 2D transthoracic echocardiograms. The platform processes DICOM images to generate a complete structured report, including automated measurements, disease detection, and clinical findings without requiring manual frame selection or annotations.
The software is built for cardiologists, sonographers, and core laboratories operating in hospitals, outpatient clinics, and clinical research settings. It is indicated for use in adult patients to support clinical decision-making by providing automated estimations of cardiac structural and functional parameters across B-mode, M-mode, and Doppler (pulsed-wave, continuous-wave, and tissue) modalities.
Us2.v2 integrates into existing clinical workflows by connecting directly to ultrasound devices, Picture Archiving and Communication Systems (PACS), Cardiovascular Information Systems (CVIS), and Electronic Medical Records (EMR). It supports both cloud-based and on-premise deployments. Once an echo study is uploaded, the software processes the data in real time, delivering editable, guideline-directed measurement outputs and structured text reports directly to the clinician for final review and validation.
Notable capabilities of the platform include:
- Comprehensive Parameter Automation: Automatically measures 45 distinct echocardiographic parameters, including strain analysis and left/right atrial and ventricular dimensions, volumes, and systolic/diastolic function.
- Zero-Click Processing: Fully automates the workflow from DICOM routing to structured report generation, eliminating manual tracing and frame selection.
- Disease-Specific Indications: Provides automated detection support for conditions such as heart failure, aortic stenosis, pulmonary hypertension, and cardiac amyloidosis.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- 100% AI automation, eliminating manual frame selection and annotation
- Delivers a complete structured echo report with measurements, disease detection, and clinical findings
- Automated detection of cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease
- Guideline-adherent and explainable AI with transparent visual overlays and editable outputs
- Compatible with any ultrasound manufacturer (e.g., GE, Philips, Siemens, handheld POCUS)
- Integrates seamlessly with existing PACS, CVIS, or EMR systems (HL7 and DICOM SR supported)
- Offers both cloud and on-premise deployment options
- Reduces reporting time by up to 70% and increases daily scan throughput
- Enterprise-wide storage options with built-in PACS compatibility
- Automates over 150 echocardiographic measurements
Use Cases
- Standardized echo reporting for clinical routine and retrospective studies
- Longitudinal surveillance and PACS-based case finding at scale
- Population health initiatives and retrospective analysis (EHR mining)
- Accelerating clinical trials and research by standardizing echo measurements
- Point-of-care ultrasound (POCUS) device integration for screening and follow-up
- Early detection and diagnosis of various heart-related conditions like heart failure and cardiac amyloidosis
What Physicians Need to Know
Us2.v2 can significantly enhance echocardiography workflows by providing fully automated, consistent, and reproducible measurements, reducing analysis time from 35-40 minutes to as little as 2-3 minutes. This allows cardiologists and sonographers to focus more on patient interaction and complex cases. The explainable AI output allows for review and editing of automated annotations and measurements, maintaining physician control and confidence in clinical decisions. Its capability to detect conditions like cardiac amyloidosis and heart failure earlier, aligned with international guidelines, can lead to improved patient outcomes and more efficient patient selection for clinical trials.
Us2.v2 is designed for seamless integration into existing clinical environments. It is vendor-agnostic, accepting DICOM images from any ultrasound device, and can connect directly to PACS, CVIS, and EMR systems. The platform offers flexible deployment options, including cloud (AWS) or on-premises. Strategic partnerships with major players like Merge Cardio, Aidoc (via aiOS), deepc (via deepcOSu00ae), and Fujifilm (with the LISENDO 880 ultrasound system) highlight its commitment to providing a consolidated and streamlined AI solution within diverse healthcare IT infrastructures, minimizing disruption to current workflows.
Details
| Category | Cardiology AI, Clinical Decision Support & Reference |
| Pricing | Contact for pricing — Custom pricing based on deployment options and features; contact sales for a formal quotation. |
| Deployment | Cloud, On-premise |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated Us2.v2 received FDA 510(k) clearance (K233676) on April 1, 2024, for viewing and quantifying cardiovascular ultrasound images in DICOM format, aiding diagnostic review and analysis of echocardiographic data, patient record management, and reporting, including comprehensive parameters like strain imaging. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology |
What the Web Says
Us2.v2 by Us2.ai is an AI-driven echocardiography analysis software that automates cardiac measurements and reporting, aiming to improve efficiency and accuracy in cardiovascular care. It has received FDA clearance and is designed to integrate seamlessly into existing clinical workflows. Physicians and sonographers generally report positive perceptions, noting improvements in measurement accuracy and workflow efficiency.
Overall: PositiveStrengths
- Real-time, fully automated image processing and analysis, reducing manual workload and analysis time.
- Reduced variability in measurements compared to human analysis, with agreement at or above inter-reader variability for key parameters.
- Automated generation of comprehensive, guideline-referenced reports, including 45 automated echo parameters and strain analysis.
- Seamless integration with existing ultrasound devices, PACS, CVIS, and EMR systems, with cloud or on-premise deployment options.
- Decision support tools allow qualified sonographers and physicians to review and edit AI-generated measurements, preserving clinical autonomy.
- Potential to increase patient throughput and access to echocardiography, especially in underserved populations, and reduce sonographer fatigue and injury.
Limitations
- Some initial skepticism and concerns from sonographers about AI potentially replacing their roles, though this is being addressed by framing AI as a supportive tool.
- Poor image capture can lead to inaccurate annotations and measurements.
- While generally positive, specific detailed reviews from individual physicians or healthcare IT professionals outside of company-published testimonials are limited in the search results.
- No specific negative feedback found on G2 or Capterra, as there are not enough reviews for Us2.ai on these platforms to provide detailed buying insight.
Based on reviews from: Us2.ai, G2, Slashdot, Reddit, DOKUMEN.PUB, accessdata.fda.gov, arXiv, Trustpilot
Last updated: 2026-07-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Us2.v2
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Us2.v2.
Akon - Don't Matter Official Music Video
Bad Boy Edd
Frequently Asked Questions
Compare Us2.v2
VS
VS
VS
VS
